Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Ved Chaturvedi"'
Autor:
Harjit Singh Nalwa, Peeyush Prasad, Nirmal Kumar Ganguly, Ved Chaturvedi, Shivani Arora Mittal
Publikováno v:
Translational Medicine Communications, Vol 8, Iss 1, Pp 1-9 (2023)
Abstract Rheumatoid Arthritis is one of the most common autoimmune diseases, causing irreversible joint damage and disability. Methotrexate (MTX) is the gold standard drug for this. The low cost, easy availability and high efficacy makes it the most
Externí odkaz:
https://doaj.org/article/42825aa7c04341d9a1388b465b443975
Autor:
Jeet Hemantkumar Patel, Ved Chaturvedi, Lalit Duggal, Neeraj Jain, Gurbir Bhandari, Monika Jain
Publikováno v:
Indian Journal of Rheumatology, Vol 17, Iss 2, Pp 142-148 (2022)
Objective: The objective of this study is to study distribution of human leukocyte antigen (HLA)-B alleles in Spondyloarthritis (SpA) and to find its clinical relevance in the patient management. Materials and Methods: A prospective, cross-sectional,
Externí odkaz:
https://doaj.org/article/94b0f12fd8314a5d9927015665f669bc
Autor:
Bhavya Chintala, Ved Chaturvedi
Publikováno v:
Indian Journal of Rheumatology, Vol 18, Iss 2, Pp 176-177 (2023)
Externí odkaz:
https://doaj.org/article/67312fb0c8734e03a2dc044d7e52e8b8
Autor:
Keerthi Talari, Vinod Ravindran, Pradip Kumar, Pravin Patil, Sarath Chandra Mouli, Syamasis Bandyopadhyay, Balebail G Dharmanand, Abhrajit Ray, Shankaralingam Rajeshwari, Sanjiv N Amin, Jyotsna Oak, Ved Chaturvedi, Anand N Malaviya, Sukumar Mukherjee
Publikováno v:
Indian Journal of Rheumatology, Vol 16, Iss 3, Pp 311-321 (2021)
Pharmacological management of rheumatoid arthritis (RA) includes synthetic and biological disease-modifying antirheumatic drugs (DMARDs). Biological DMARDs, also referred to as “biologics,” rapidly retard progression of the joint damage seen in R
Externí odkaz:
https://doaj.org/article/8afbed8558ee4037a7ddc3fa0f34c61f
Autor:
Jeet Hemantkumar Patel, Lalit Duggal, Ved Chaturvedi, Neeraj Jain, Gurbir Bhandari, Mayank Gupta
Publikováno v:
Indian Journal of Rheumatology, Vol 15, Iss 6, Pp 200-204 (2020)
Objective: Intravenous immunoglobulin (IVIG) has been used in the treatment of severe idiopathic inflammatory myositis (IIM) in the past. We conducted a retrospective analysis of IIM cases and compared patients who received IVIG with those who did no
Externí odkaz:
https://doaj.org/article/f8aaf2bdb40b4e0fad85379d89f22a3c
Autor:
Durga Prasanna Misra, Vinod Ravindran, Aman Sharma, Anupam Wakhlu, Vir Singh Negi, Ved Chaturvedi, Vikas Agarwal
Publikováno v:
Indian Journal of Rheumatology, Vol 15, Iss 2, Pp 92-99 (2020)
Background: We surveyed rheumatology consultants regarding their perceptions about rheumatology practice and training in India. Materials and Methods: A structured questionnaire was administered during two national rheumatology meetings to evaluate p
Externí odkaz:
https://doaj.org/article/3a1f52c7ba9f4619850ebaf92b62d845
Autor:
Molly Mary Thabah, Ved Chaturvedi
Publikováno v:
Journal of Mahatma Gandhi Institute of Medical Sciences, Vol 19, Iss 1, Pp 12-18 (2014)
Monoarthritis can be inflammatory or non-inflammatory, and can be acute or chronic. A thorough history and physical examination can differentiate inflammatory from non-inflammatory monoarthritis. The most common causes of acute inflammatory monoarthr
Externí odkaz:
https://doaj.org/article/21898f462ef74de3aa2e82005a5a5f6d
Autor:
Ved Chaturvedi
Publikováno v:
Indian Journal of Rheumatology, Vol 13, Iss 5, Pp 2-2 (2018)
Externí odkaz:
https://doaj.org/article/12ab6605096d43dcb51f15cab0dcc447
Publikováno v:
Indian Journal of Rheumatology.
Autor:
null Surbhi, Ayushi Goel, Ved Chaturvedi, Sneha Verma, Sonia Rawat, Nirmal Kumar Ganguly, Shivani Arora Mittal
Rheumatoid Arthritis (RA), an autoimmune disease, primarily affects synovial joints but has systemic manifestations upon progression. Considering limited specific diagnostic and prognostic biomarkers, identifying the disease early and monitoring its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0fc8cf83c784fc309dca9175d077e41
https://doi.org/10.1101/2022.09.07.22279672
https://doi.org/10.1101/2022.09.07.22279672